David Gentien
Institut Curie(FR)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Ocular Oncology and Treatments, Advanced Breast Cancer Therapies, Cancer Cells and Metastasis, Breast Cancer Treatment Studies
Most-Cited Works
- → Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial(2015)1,100 cited
- → SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma(2013)429 cited
- → Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)(2014)402 cited
- → Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges(2017)233 cited
- → A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts(2018)218 cited
- → Molecular profiling of patient-derived breast cancer xenografts(2012)190 cited
- → Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer(2012)190 cited
- → Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target(2014)174 cited
- → Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors(2010)171 cited
- → TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer(2013)168 cited